Obstetrics and gynecology
-
Obstetrics and gynecology · Jan 2019
Randomized Controlled TrialEffects of Two Educational Posters on Contraceptive Knowledge and Intentions: A Randomized Controlled Trial.
To compare the Centers for Disease Control and Prevention's (CDC) contraceptive effectiveness poster with a more patient-centered poster on factors affecting the likelihood of using effective contraceptives. ⋯ ClinicalTrials.gov, NCT03372369.
-
Obstetrics and gynecology · Nov 2018
Randomized Controlled Trial Multicenter StudyElagolix Alone or With Add-Back Therapy in Women With Heavy Menstrual Bleeding and Uterine Leiomyomas: A Randomized Controlled Trial.
To evaluate elagolix, an oral gonadotropin-releasing hormone receptor antagonist, alone or with add-back therapy, in premenopausal women with heavy menstrual bleeding (greater than 80 mL per month) associated with uterine leiomyomas. ⋯ ClinicalTrials.gov, NCT01817530; EU Clinical Trial Register, 2013-000082-37.
-
Obstetrics and gynecology · Nov 2018
Randomized Controlled TrialTorsemide for Prevention of Persistent Postpartum Hypertension in Women With Preeclampsia: A Randomized Controlled Trial.
To evaluate whether torsemide reduces the rate of persistent postpartum hypertension in women with preeclampsia. ⋯ ClinicalTrials.gov, NCT02813551.
-
Obstetrics and gynecology · Sep 2018
Randomized Controlled Trial Comparative StudyIndividualized Compared With Standard Postdischarge Oxycodone Prescribing After Cesarean Birth: A Randomized Controlled Trial.
To evaluate whether individualized postdischarge oxycodone prescribing guided by inpatient opioid use reduces the number of unused opioid tablets after cesarean birth. ⋯ ClinicalTrials.gov, NCT03168425.
-
Obstetrics and gynecology · Aug 2018
Randomized Controlled Trial Multicenter StudyProphylactic Negative Pressure Wound Therapy and Wound Complication After Cesarean Delivery in Women With Class II or III Obesity: A Randomized Controlled Trial.
To compare the occurrence of superficial surgical site infections in obese women using prophylactic negative pressure therapy with standard dressings after cesarean delivery. ⋯ ClinicalTrials.gov, NCT02390401.